You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Triple Negative

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Tumors Trial (Xiaopi granules, Xiaopi decoction, Placebo)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Xiaopi granules
  • +2 more
  • (no location specified)
Nov 22, 2023

Triple Negative Breast Cancer Trial (Proleukin 1.3 MG Injection)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Proleukin 1.3 MG Injection
  • (no location specified)
Apr 6, 2023

Immunotherapy-related CRP Kinetics in Early and Metastatic

Recruiting
  • TNBC - Triple-Negative Breast Cancer
    • Tuebingen, Germany
      Department of Women's Health
    Jun 13, 2023

    Looking At Triple Negative Breast Cancer Patient Experience

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Breast Cancer
      • (no location specified)
      Mar 3, 2023

      Triple Negative Breast Tumors Trial (Pembrolizumab injection, Capecitabine tablets, Local radiotherapy)

      Not yet recruiting
      • Triple Negative Breast Neoplasms
      • Pembrolizumab injection
      • +2 more
      • (no location specified)
      Jul 25, 2023

      Triple Negative Breast Cancer, Neoadjuvant Chemo, Pembrolizumab Trial in Seoul (Visium, Whole Genome Sequencing(WGS)/Whole

      Recruiting
      • Triple Negative Breast Cancer
      • +3 more
      • Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Jun 15, 2023

      TNBC - Triple-Negative Breast Cancer Trial in Wuhan (Utidelone, Tirelizumab, Bevacizumab)

      Recruiting
      • TNBC - Triple-Negative Breast Cancer
      • Wuhan, Hubei, China
        Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
      Nov 5, 2023

      Triple Negative Breast Tumors Trial in Paris (Atezolizumab + RP1)

      Not yet recruiting
      • Triple Negative Breast Neoplasms
      • Atezolizumab + RP1
      • Paris, France
        Institut Curie
      Oct 2, 2023

      Triple Negative Breast Cancer Trial in Dhaka (Doxorubicin, Cyclophosphamide, Paclitaxel)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • Dhaka, Bangladesh
        Bangabandhu Sheikh Mujib Medical University
      May 24, 2023

      Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)

      Not yet recruiting
      • Metastatic Triple-Negative Breast Cancer
      • Charlotte, North Carolina
        Levine Cancer Institute
      Aug 31, 2023

      TNBC - Triple-Negative Breast Cancer Trial in Brussels (Ga-PSMA PET/CT)

      Recruiting
      • TNBC - Triple-Negative Breast Cancer
      • Ga-PSMA PET/CT
      • Brussels, Belgium
        Institut Jules Bordet
      Sep 26, 2023

      Triple Negative Breast Cancer Trial (Sacituzumab govitecan, Pembrolizumab)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • (no location specified)
      Oct 5, 2023

      Breast Cancer Trial in Beijing (99mTc-MY6349 SPECT/CT scan)

      Recruiting
      • Breast Cancer
      • 99mTc-MY6349 SPECT/CT scan
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Oct 24, 2023

      Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant

      Not yet recruiting
      • Breast Cancer Triple Negative
      • +3 more
        • Atlanta, Georgia
          Emory University/Winship Cancer Institute
        May 18, 2023

        Checkpoint Inhibitors in Triple Negative Breast

        Recruiting
        • Triple Negative Breast Cancer
        • Whole Genome Sequencing
        • +7 more
        • Barcelona, Spain
          Vall d'Hebron Institute of Oncology
        Jun 20, 2023

        TNBC - Triple-Negative Breast Cancer Trial (Camrelizumab Plus Chemotherapy and Famitinib, Camrelizumab Plus Chemotherapy)

        Not yet recruiting
        • TNBC - Triple-Negative Breast Cancer
        • Camrelizumab Plus Chemotherapy and Famitinib
        • Camrelizumab Plus Chemotherapy
        • (no location specified)
        Aug 17, 2023

        Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)

        Not yet recruiting
        • Breast Cancer
        • Triple Negative Breast Cancer
        • (no location specified)
        Jun 11, 2023

        Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

        Not yet recruiting
        • Triple Negative Breast Cancer
        • +2 more
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Jul 25, 2023

        Advanced Triple Negative Breast Cancer Trial in Shantou (SZ011 CAR-NK)

        Not yet recruiting
        • Advanced Triple Negative Breast Cancer
        • SZ011 CAR-NK
        • Shantou, China
          Shantou
        Jan 9, 2023

        Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-low Breast Cancer Trial in Carmel, Indianapolis

        Not yet recruiting
        • Metastatic Breast Cancer
        • +2 more
        • Carmel, Indiana
        • +2 more
        Apr 27, 2023

        Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Shanghai (proton plus carbon ion radiotherapy)

        Recruiting
        • Triple Negative Breast Cancer
        • HER2-positive Breast Cancer
        • proton plus carbon ion radiotherapy
        • Shanghai, China
          Shanghai Proton and Heavy Ion center
        Jan 11, 2023

        Molecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in

        Not yet recruiting
        • Metastatic Triple-Negative Breast Carcinoma
        • 89Zr-atezolizumab PET/CT
        • (no location specified)
        Feb 22, 2023

        TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,

        Not yet recruiting
        • TNBC - Triple-Negative Breast Cancer
        • (no location specified)
        May 8, 2023

        TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

        Not yet recruiting
        • TNBC - Triple-Negative Breast Cancer
        • Alkaline Glucosodiene Molecules
        • (no location specified)
        Jul 14, 2023

        Breast Tumors Trial in Hangzhou (Sindilimab, Nab-paclitaxel, Lenvatinib)

        Not yet recruiting
        • Breast Neoplasms
        • Hangzhou, Zhejiang, China
          ZhejiangCH
        Nov 17, 2023